Side-by-side IPO readiness, funding history, and valuation comparison. Data sourced by TechStackIPO.
Scores, valuations, and signals for SpaceX, Tempus AI, and 370+ companies. 5-min read every Tuesday.
Aerospace and defense company with proprietary reusable rocket technology. Confidential S-1 filed April 2026 targeting $75B Nasdaq IPO at $1.75T valuation. $20B projected 2026 revenue, $14B EBITDA. Government contracts with NASA and DoD.
| Industry | Aerospace & Defense |
| Stage | Pre-IPO |
| IPO Status | Pre-IPO |
| Valuation | $1.75T |
| Total Funding | $11.9B |
| Headquarters | Hawthorne, CA |
AI-powered precision medicine platform analyzing clinical and molecular data.
| Industry | Biotechnology |
| Stage | Recent IPO |
| IPO Status | Public |
| Valuation | $8B |
| Total Funding | $1.3B |
| Headquarters | Chicago, IL |
SpaceX is valued at $1.75T. Tempus AI is valued at $8B. Both valuations are based on the most recent private funding rounds tracked by TechStackIPO.
SpaceX has raised $11.9B. Tempus AI has raised $1.3B.
SpaceX is currently pre-IPO. Tempus AI is currently already public. Track both on TechStackIPO for S-1 filings and IPO announcements.
SpaceX operates in Aerospace & Defense, while Tempus AI operates in Biotechnology.
SpaceX is a Aerospace & Defense company valued at $1.75T with $11.9B raised. Tempus AI is a Biotechnology company valued at $8B with $1.3B raised. See TechStackIPO's full side-by-side comparison for IPO readiness scores, funding timelines, and investor data.
Accredited investors can access pre-IPO shares in SpaceX and Tempus AI through secondary market platforms, pre-IPO funds, and broker-dealer platforms that facilitate private company transactions. TechStackIPO's marketplace section tracks available access options for both companies. Pre-IPO investments carry higher risk and limited liquidity.